This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Robert Mayer
GDD TRD biologics at Novartis

Profile

Robert Mayer, Ph.D., has completed his Ph.D. at the University of Innsbruck in the field of analytical chemistry. After completion, he joined Sandoz GmbH in 2009 in the position as laboratory head in the working group for protein characterization. Since 2010 Robert Mayer has been the responsible project analyst for different biosimilar products, such as GP2015, which was approved by the FDA, EMA and other health agencies as a biosimilar to Enbrel®.

Agenda Sessions

  • Quality by Design in Analytics

    11:00am
  • Quality by Design in Analytics

    11:00am

Speakers at this event